Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.

导出 LinkOut

翻译打印收藏纠错

作者： Chantal,Reina-Ortiz ^[1] ; Michael,Constantinides ^[2] ; Alexis,Fayd-Herbe-de-Maudave ^[2] ; Jessy,Présumey ^[2] ; Javier,Hernandez ^[2] ; Guillaume,Cartron ^[3] ; David,Giraldos ^[1] ; Rosana,Díez ^[4] ; Isabel,Izquierdo ^[4] ; Gemma,Azaceta ^[5] ; Luis,Palomera ^[5] ; Isabel,Marzo ^[1] ; Javier,Naval ^[1] ; Alberto,Anel ^[1] ; Martín,Villalba ^[2]

作者单位： Apoptosis, Immunity & Cancer Group, Dept. Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Sq., University of Zaragoza and Aragón Health Research Institute (IIS Aragón), Zaragoza, Spain. ^[1] CHU Montpellier, IRMB, Montpellier, France. ^[2] Département d'Hématologie Clinique, CHU, Montpellier, France. ^[3] Hematology Department, Miguel Servet Hospital, Zaragoza, Spain. ^[4] Hematology Department, Lozano Blesa Hospital, Zaragoza, Spain. ^[5] IRMB, Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France. ^[6]

关键词 Multiple Myeloma NK cells PD-1 cell Therapy and Immunotherapy cytotoxicity daratumumab

主题词成年人(Adult);抗体, 单克隆(Antibodies, Monoclonal);胎血(Fetal Blood);人类(Humans);杀伤细胞, 天然(Killer Cells, Natural);多发性骨髓瘤(Multiple Myeloma)

DOI 10.1080/2162402X.2020.1853314

PMID 33457074

发布时间 2021-07-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交